A61P 13 - Drugs for disorders of the urinary system

Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
10/2002
10/31/2002	US20020160992 Reversing advanced glycosylation cross-links using heterocyclic-substituted thiazolium salts
10/31/2002	US20020160987 Novel 4-dedimethylaminotetracycline derivatives
10/31/2002	US20020160984 For example, 2,3-dihydro-1H-benz(de)isoquinolin-1-one; treating diabetes, cancer, radiosensitizing tumor cells, cardiovascular disorders, septic shock, inflammatory bowel disease, senescent cells
10/31/2002	US20020160963 Aminomethyl-pyrroloquinazoline compounds as thrombin receptor antagonists
10/31/2002	US20020160955 Protein variants
10/31/2002	US20020160948 Such as preventing or treating primary cancer cell growth
10/31/2002	US20020160499 For use in diagnosis, prophylaxis, and therapy of disorders associated with expression of serine carboxypeptidase
10/31/2002	US20020160478 Short peptides which selectively modulate the activity of protein kinases
10/31/2002	US20020159968 A stable polyallylamine hydrochloride polymer crosslinked by epichlorohydrin
10/31/2002	CA2445888A1 Chiral, broad-spectrum antibacterial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation and compositions
10/31/2002	CA2445740A1 Use of metals to treat inflammatory skin conditions
10/31/2002	CA2445734A1 Medicament containing a metal such as silver, gold, platinum or palladium as an antimicrobial agent and their use to induce apoptosis in cancerous tissue
10/31/2002	CA2445729A1 Use of metals to treat mucosal membranes
10/31/2002	CA2445233A1 Phthalazinones derivatives useful as pde4/7 inhibitors
10/31/2002	CA2445188A1 Arylindenopyridines with pde inhibiting activity
10/31/2002	CA2445168A1 Human timp-1 antibodies
10/31/2002	CA2444675A1 Secreted proteins
10/31/2002	CA2444595A1 Benzimidazolone derivatives
10/31/2002	CA2444370A1 Use of radical scavenging compounds for treatment and prevention of no-dependent microcirculation disorders
10/31/2002	CA2444347A1 Method for treating gout and binding uric acid
10/31/2002	CA2444235A1 New polynucleotides and polypeptides of the ifn.alpha.-17 gene
10/31/2002	CA2444219A1 Antiangiogenic combination therapy for the treatment of cancer
10/31/2002	CA2443600A1 Heterocyclyldicarbamides as caspase inhibitors
10/31/2002	CA2443587A1 Therapeutic treatments using the direct application of antimicrobial metal compositions
10/31/2002	CA2443373A1 New polynucleotides and polypeptides of the erythropoietin gene
10/31/2002	CA2442591A1 Favorable modulation of health-related quality of life and health-related quality-adjusted time-to-progression of disease in patients with prostate cancer
10/30/2002	EP1252189A2 Novel human nucleic acid molecules and polypeptides encoding cation channels
10/30/2002	EP1252165A1 Isoxazolo pyrimidinones and the use thereof
10/30/2002	EP1252161A1 Pyrrolo-isoquinoline and tetrahydropyrrolo-isoquinoline derivatives and their use as mediators of the 5-ht7 receptor
10/30/2002	EP1252158A1 Nicotinamide benzofused-heterocyclyl derivatives useful as selective inhibitors of pde4 isozymes
10/30/2002	EP1252157A1 Pyrimidine carboxamides useful as inhibitors of pde4 isozymes
10/30/2002	EP1252154A1 Heterocyclic amide derivatives
10/30/2002	EP1252150A1 Novel heterocyclic derivatives, preparation method and pharmaceutical compositions containing same
10/30/2002	EP1252144A1 Substituted glutarimides and use thereof il-12 production inhibitors
10/30/2002	EP1252143A1 Method for preparing alpha-sulfonyl hydroxamic acid derivatives
10/30/2002	EP1251848A1 Gyrase inhibitors and uses thereof
10/30/2002	EP1251739A2 Poly(dipeptide) as a drug carrier
10/30/2002	CN1377424A Methods of reparing tandemly repeated DNA sequences and extending cell life-span using nuclear transfer
10/30/2002	CN1377356A Certain alkylene diamine-substituted heterocycles
10/30/2002	CN1377279A Use of soluble cosmetimulatory molecules to enhance immune responses
10/30/2002	CN1377271A Use of thienopyrimidines
10/30/2002	CN1377259A ACE-2 inhibiting compounds and methods of use thereof
10/30/2002	CN1376517A Medicine for preventing and treating renal fibrosis
10/30/2002	CN1376515A Medicine for preventing and treating nephrosis
10/30/2002	CN1093414C Suppository for treating prostatic disease and preparing method thereof
10/30/2002	CN1093412C Chinese medicine for curing lithiasis
10/30/2002	CA2383469A1 Treatment of t-cell mediated diseases
10/29/2002	US6472581 Silicone sheet and surgical bandage manufactured using the same
10/29/2002	US6472526 Shows an inhibitory activity against farnesyl transferase or pharmaceutically acceptable salts or isomers thereof, in pharmaceutical composition and intermediates
10/29/2002	US6472412 Compounds as PDE IV and TNF inhibitors
10/29/2002	US6472411 Advanced glycation end-product intermediaries and post-amadori inhibition
10/29/2002	US6472400 Advanced gylcation end-product intermediaries and post-Amadori inhibition
10/29/2002	US6472378 Compositions and methods for treatment of mitochondrial diseases
10/29/2002	US6472374 Endometrial function
10/29/2002	US6472165 Modulatory binding site in potassium channels for screening and finding new active ingredients
10/29/2002	US6471997 Antagonist of calcitonin gene related peptide, cgrp and/or of substance p; cosmetic
10/25/2002	WO2001083451A1 Novel bicyclic compounds
10/24/2002	WO2002084298A2 Medicaments which are modulators of hm74 and/or hm74a activity
10/24/2002	WO2002083874A2 Endothelial cell expression patterns
10/24/2002	WO2002083873A2 Enzymes
10/24/2002	WO2002083736A2 G-protein coupled receptor molecules and uses thereof
10/24/2002	WO2002083709A2 Kinases and phosphatases
10/24/2002	WO2002083704A1 Vascular endothelial growth factor 2
10/24/2002	WO2002083700A2 Hypersulfated disaccharides and methods of using the same for the treatment of inflammations
10/24/2002	WO2002083685A1 Cyclohexylphenyl vasopressin agonists
10/24/2002	WO2002083681A1 Novel cyclohexenyl phenyl diazepines vasopressin and oxytocin receptor modulators
10/24/2002	WO2002083668A1 Isoxaxole derivatives as inhibitors of src and other protein kinases
10/24/2002	WO2002083667A2 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
10/24/2002	WO2002083664A1 3-substituted quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists
10/24/2002	WO2002083663A1 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists
10/24/2002	WO2002083658A1 Piperazine-benzamide derivatives useful as apob-100 and/or mtp inhibitor
10/24/2002	WO2002083645A1 Novel compounds
10/24/2002	WO2002083643A1 Phenyl heterocyclyl ether derivatives as serotonin re-uptake inhibitors
10/24/2002	WO2002083642A1 Compounds useful as anti-inflammatory agents
10/24/2002	WO2002083628A1 1,4-disubstituted benzo-fused compounds
10/24/2002	WO2002083627A2 Ligands des integrins avss6
10/24/2002	WO2002083624A1 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands
10/24/2002	WO2002083185A1 Method of gene transfer via vascular system or ureter
10/24/2002	WO2002083159A1 Palliative effects of morinda citrifolia oil and juice
10/24/2002	WO2002083154A1 Use of cationic dextran derivatives for protecting dose-limiting organs
10/24/2002	WO2002083145A1 N-biphenylcarbonyl- and n-phenylpyridylcarbonyl substituted bi- and tricyclic azepines and diazepines as vasopressing agonists
10/24/2002	WO2002083143A1 Cxcr3 antagonists
10/24/2002	WO2002083142A1 Novel use of arylethenesulfonamide derivative
10/24/2002	WO2002083135A2 Use of buprenorphine for the manufacture of a transdermal delivery device for the treatment of urinary incontinence, especially urge incontinence
10/24/2002	WO2002083127A1 Protein modification-inhibitory compositions
10/24/2002	WO2002083112A2 Method for the treatment of polycystic kidney disease
10/24/2002	WO2002083111A2 Imidazole, thiazole and oxazole derivatives and their use for the manufacture of a medicament for the treatment and/or prevention of pollakiuria or urinary incontinence
10/24/2002	WO2002083066A2 Amino acid complexes of c-aryl glucosides for treatment of diabetes and method
10/24/2002	WO2002060534A3 Selective alpha 1 antagonists a + d
10/24/2002	WO2002053140A3 New drug combinations of norepinehrine reuptake inhibitors and neuroleptic agents
10/24/2002	WO2002051848A3 Sulfamidothienopyrimidines and the use of the same as phosphodiesterase v inhibitors
10/24/2002	WO2002050065A3 Pyrazole compounds useful as protein kinase inhibitors
10/24/2002	WO2002040038A3 M. tuberculosis chaperonin 10 and uses thereof
10/24/2002	WO2001077375A8 Diagnosis of diseases associated with gene regulation
10/24/2002	WO2001076568B1 Use of 13-hode as a regulator of vascular biocompatibility and an inhibitor of cell hyperplasia
10/24/2002	US20020156266 Sodium phosphate cotransporter expressed on apical surface of intestinal epithelial cells (huNpt2B) and polypeptides related thereto
10/24/2002	US20020156111 Substituted bicyclic compounds
10/24/2002	US20020156104 Novel pyrazole and pyrazoline substituted compounds
10/24/2002	US20020156090 Estrogen agonist/antagonist to prevente myocardial infarction or stroke, maintaining or improving vascular reactivity, treat renal failure, peripheral arterial occlusive disease, coronary artery disease, or raynaud's phenomenon
10/24/2002	US20020156085 1,4-Disubstituted piperazine derivatives useful as uro-selective alpha1-adrenoceptor blockers

1 ... 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 ... 562